DUBLIN--(BUSINESS WIRE)--The "Anticoagulants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Anticoagulants in US$ Million by the following Segments:
- Oral Anticoagulants
- Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin)
The report profiles 48 companies including many key and niche players such as:
- Abbott India Limited (India)
- Aspen Holdings (South Africa)
- Bayer AG (Germany)
- Boehringer Ingelheim (Germany)
- Bristol-Myers Squibb Company (USA)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Pfizer, Inc. (USA)
- Sanofi S.A. (France)
- Teva Pharmaceutical Industries Ltd. (Israel)
Key Topics Covered:
1. Global Market Overview
2. Market Trends & Issues
3. Segment Analysis
4. Therapeutic Indications
5. Product Introductions/Approvals
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
Total Companies Profiled: 48 (including Divisions
Subsidiaries - 58)
- The United States (23)
- Japan (3)
-
Europe (30)
- France (1)
- Germany (4)
- The United Kingdom (4)
- Spain (1)
- Rest of Europe (5)
- Asia-Pacific (Excluding Japan) (15)
- Africa (2)
For more information about this report visit https://www.researchandmarkets.com/research/zt4sg8/global?w=4